GENEVA, July 6 -- BIOSSIL INC. filed a patent application (CA2025/051741) for “ADJUNCT THERAPY FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME”. With publication no. WO/2026/137073, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/165
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....